穿戴式注射器市場規模、佔有率、成長分析、按類型、按技術、按適應症、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球穿戴式注射器市場規模為66.6億美元，從2023年的76.5億美元擴大到2031年的238.9億美元，預測期（2024-2031）預計複合年成長率為15.29%。

穿戴式注射器正在徹底改變患者照護，提高患者和醫護人員的安全性，並顯著降低與傳統注射方法（例如插入和拔針）相關的風險。隨著已開發國家和開發中國家的醫療保健成本不斷上升，這種創新注射器提供了一種解決方案，可提供高品質、負擔得起的醫療保健。患者可以在家中方便地進行皮下注射，從而減少醫院就診次數和相關費用。注射器的方便用戶使用設計允許用戶透過按鈕啟動設備，確保無縫針頭插入。給藥後，針頭會自動縮回，因此不存在針刺傷的可能性。這項先進技術不僅提高了安全性，還簡化了注射過程，使其成為現代醫療保健的重要組成部分。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究
• 客戶和購買標準分析

穿戴式注射器市場規模：按類型和複合年成長率（2024-2031）

• 市場概況
• 體內穿戴式注射器
• 離體穿戴式注射器
• 裝置專用穿戴式注射器

穿戴式注射器市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 彈簧底座
• 馬達驅動
• 擴充電池
• 旋轉泵
• 其他

穿戴式注射器市場規模：按適應症和複合年成長率（2024-2031）

• 市場概況
• 糖尿病
• 免疫腫瘤學
• 心血管
• 慢性疼痛

穿戴式注射器市場規模：依最終用戶和複合年成長率（2024-2031）

• 市場概況
• 醫院/診所
• 居家護理
• 其他

穿戴式注射器市場規模：按地區及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Becton Dickinson（BD）
• Insulet Corporation
• Ypsomed Holding AG
• Tandem Diabetes Care
• Enable Injections
• West Pharmaceutical Services
• Stevanato Group
• Eitan Medical
• Sensile Medical
• Buhler Motor
• United Therapeutics
• Dexcom
• CeQur
• Phillips-Medisize
• Medtronic
• Amgen
• Oval Medical Technologies
• Gerresheimer AG
• Terumo Corporation
• BioCorp

結論和建議

Global Wearable Injectors Market size was valued at USD 6.66 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031).

Wearable injectors are revolutionizing patient care by enhancing safety for both patients and healthcare workers, significantly mitigating risks associated with traditional injection methods, such as needle insertion and removal. As healthcare costs rise in both developed and developing nations, these innovative injectors present a solution for delivering high-quality, affordable care. Patients can administer subcutaneous injections conveniently at home, reducing hospital visits and associated costs. With a user-friendly design, the injector allows users to activate the device with a button, ensuring seamless needle insertion. After medication delivery, the device retracts the needle automatically, eliminating the possibility of needle stick injuries. This advanced technology not only enhances safety but also streamlines the injection process, making it an essential component of modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Wearable Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Wearable Injectors Market Segmental Analysis

Global Wearable Injectors Market is segmented by Type, Technology, Indications, End User and region. Based on Type, the market is segmented into On-body Wearable Injectors, Off-body Wearable Injectors, Device-Only Wearable Injectors. Based on Technology, the market is segmented into Spring-Based, Motor Drive, Expanding Battery, Rotary Pump, Other. Based on Indications, the market is segmented into Diabetes, Immuno- Oncology, Cardiovascular, Chronic Pain. Based on End User, the market is segmented into Hospital & Clinic, Homecare, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Wearable Injectors Market

The growing prevalence of chronic diseases significantly fuels the expansion of the wearable injectors market. With a rise in the number of patients suffering from conditions such as diabetes, cardiovascular diseases, and cancer, the demand for these devices is surging. Wearable injectors offer a more convenient and less painful method for medication administration, which enhances patient adherence to treatment regimens. As the global burden of chronic illnesses escalates, particularly among the aging population, the adoption of wearable injectors is projected to rise. This trend reflects a broader shift toward innovative healthcare solutions that prioritize patient comfort and compliance.

Restraints in the Global Wearable Injectors Market

A significant constraint facing the global wearable injectors market is the elevated pricing associated with these devices. The integration of advanced technology and intricate manufacturing processes contributes to their high cost, rendering them less accessible to many users. This economic barrier presents a considerable challenge, particularly in developing and low-income regions, where affordability becomes a critical issue. As a result, the high prices of wearable injectors can hinder widespread adoption and limit market growth, creating disparities in access to these innovative healthcare solutions in different parts of the world.

Market Trends of the Global Wearable Injectors Market

The Global Wearable Injectors market is witnessing a significant trend towards personalized medicine, driven by the increasing development of biopharmaceutical products tailored to individual patient needs. As healthcare providers and manufacturers focus on delivering customized treatment regimens, wearable injectors are evolving to accommodate personalized medication delivery systems. This shift enhances patient outcomes by ensuring greater adherence and accuracy in drug administration. Furthermore, the rising demand for patient-centric solutions is revitalizing the market, fostering innovation in wearable injector technology that aligns with the broader trend of precision medicine, ultimately shaping the future of therapeutic delivery in healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis

Global Wearable Injectors Market Size by Type & CAGR (2024-2031)

• Market Overview
• On-body Wearable Injectors
• Off-body Wearable Injectors
• Device-Only Wearable Injectors

Global Wearable Injectors Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Spring-Based
• Motor Drive
• Expanding Battery
• Rotary Pump
• Other

Global Wearable Injectors Market Size by Indications & CAGR (2024-2031)

• Market Overview
• Diabetes
• Immuno- Oncology
• Cardiovascular
• Chronic Pain

Global Wearable Injectors Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospital & Clinic
• Homecare
• Other

Global Wearable Injectors Market Size & CAGR (2024-2031)

• North America, (Type, Technology, Indications, End User)
  • US
  • Canada
• Europe, (Type, Technology, Indications, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Technology, Indications, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Technology, Indications, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Technology, Indications, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Becton Dickinson (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enable Injections
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eitan Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensile Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Buhler Motor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeQur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phillips-Medisize
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oval Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation